| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b30e265907ddcd6f8936a43ade50ecb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-22 |
| filingDate |
2022-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48fd3757e1e2318013bc9d2f44b1a1a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cbb37a076462a2575abde5d8011410b |
| publicationDate |
2022-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022268238-A1 |
| titleOfInvention |
Urine progenitor cells for use in cancer therapy |
| abstract |
The present invention relates to urine progenitor cells for use in the treatment of cancer. In particular, the treatment of cancer includes decreasing the amount of cancer cells and/or decreasing viability of cancer cells and/or decreasing the tumor size in cancer patients and/or reducing the tumor metastasis. |
| priorityDate |
2021-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |